Novo Nordisk
Pernille Høngaard has a robust background in the pharmaceutical industry, currently serving as a Strategy & Operations leader at Novo Nordisk since July 2024. Prior experience includes a role as Portfolio Manager at Teva Pharmaceuticals from November 2018 to August 2023 and a series of positions at GlaxoSmithKline Pharma, where responsibilities ranged from Business Insights to Senior Business Insight Manager, spanning from August 2010 to October 2018. Earlier career stages involved significant contributions at Nycomed as a Senior Project Manager/M&A and Senior Business Analyst, among other roles, from June 2004 to August 2010. Pernille Høngaard holds a master's degree in business economics (cand. negot.) from Syddansk Universitet - University of Southern Denmark, completed in January 1998.
This person is not in any teams
This person is not in any offices
Novo Nordisk
378 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.